Title
Category
Credits
Event date
Cost
CRS and ICANS Management in CAR T/Bispecific Antibody Therapies
  • Management of Immunotherapy-Related Toxicities
  • 0.75 ANCC contact hours
  • 0.75 Participation
$0.00
As these therapies continue to evolve, it is imperative that nursing policies are created/revised and shared with nursing staff to remain up to date on current clinical practice for these complications. With continued education and reinforcement of protocols, nurses can positively impact patient outcomes.